Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age.

Garland SM, Joura EA, Ault KA, Bosch FX, Brown DR, Castellsagué X, Ferenczy A, Ferris DG, Giuliano AR, Hernandez-Avila M, Huh WK, Iversen OE, Kjaer SK, Kurman RJ, Luna J, Monsonego J, Muñoz N, Paavonen J, Pitisuttihum P, Ronnett BM, Steben M, Stoler MH, Wheeler CM, Wiley DJ, Perez G, Saah AJ, Luxembourg A, Li S, DiNubile MJ, Wagner M, Velicer C.

Obstet Gynecol. 2018 Aug;132(2):261-270. doi: 10.1097/AOG.0000000000002736.

PMID:
29995724
2.

Eurogin roadmap 2017: Triage strategies for the management of HPV-positive women in cervical screening programs.

Cuschieri K, Ronco G, Lorincz A, Smith L, Ogilvie G, Mirabello L, Carozzi F, Cubie H, Wentzensen N, Snijders P, Arbyn M, Monsonego J, Franceschi S.

Int J Cancer. 2018 Aug 15;143(4):735-745. doi: 10.1002/ijc.31261. Epub 2018 Feb 8. Review.

3.

Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region.

Castellsagué X, Ault KA, Bosch FX, Brown D, Cuzick J, Ferris DG, Joura EA, Garland SM, Giuliano AR, Hernandez-Avila M, Huh W, Iversen OE, Kjaer SK, Luna J, Monsonego J, Muñoz N, Myers E, Paavonen J, Pitisuttihum P, Steben M, Wheeler CM, Perez G, Saah A, Luxembourg A, Sings HL, Velicer C.

Papillomavirus Res. 2016 Dec;2:61-69. doi: 10.1016/j.pvr.2016.03.002. Epub 2016 Mar 14.

4.

Is there an increased risk of cancer among spouses of patients with an HPV-related cancer: A systematic review.

Mirghani H, Sturgis EM, Aupérin A, Monsonego J, Blanchard P.

Oral Oncol. 2017 Apr;67:138-145. doi: 10.1016/j.oraloncology.2017.02.024. Epub 2017 Feb 28. Review.

PMID:
28351568
5.

Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice.

Wentzensen N, Arbyn M, Berkhof J, Bower M, Canfell K, Einstein M, Farley C, Monsonego J, Franceschi S.

Int J Cancer. 2017 May 15;140(10):2192-2200. doi: 10.1002/ijc.30579. Epub 2017 Jan 11. Review.

6.

Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.

Brotherton JM, Jit M, Gravitt PE, Brisson M, Kreimer AR, Pai SI, Fakhry C, Monsonego J, Franceschi S.

Int J Cancer. 2016 Aug 1;139(3):510-7. doi: 10.1002/ijc.30063. Epub 2016 Mar 22. Review.

7.

Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial.

Monsonego J, Cox JT, Behrens C, Sandri M, Franco EL, Yap PS, Huh W.

Gynecol Oncol. 2015 Apr;137(1):47-54. doi: 10.1016/j.ygyno.2015.01.551. Epub 2015 Feb 8.

8.

Images in clinical medicine. Ectopia lentis in Marfan's syndrome.

Lally DR, Monsonego J.

N Engl J Med. 2014 Nov 6;371(19):e28. doi: 10.1056/NEJMicm1314140. No abstract available.

9.

Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease.

Joura EA, Ault KA, Bosch FX, Brown D, Cuzick J, Ferris D, Garland SM, Giuliano AR, Hernandez-Avila M, Huh W, Iversen OE, Kjaer SK, Luna J, Miller D, Monsonego J, Munoz N, Myers E, Paavonen J, Pitisuttithum P, Steben M, Wheeler CM, Perez G, Saah A, Luxembourg A, Sings HL, Velicer C.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):1997-2008. doi: 10.1158/1055-9965.EPI-14-0410.

10.

EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection.

Giuliano AR, Nyitray AG, Kreimer AR, Pierce Campbell CM, Goodman MT, Sudenga SL, Monsonego J, Franceschi S.

Int J Cancer. 2015 Jun 15;136(12):2752-60. doi: 10.1002/ijc.29082. Epub 2014 Jul 26. Review.

11.

[HPV testing in prevention of cervical cancer: practices and current trends].

Monsonego J.

Ann Biol Clin (Paris). 2013 Nov;71:27-32. doi: 10.1684/abc.2013.0907. Review. French.

PMID:
24235325
12.

[Prevalence of genotype-specific HPV infection among women in France: implications for screening and vaccination].

Monsonego J, Zerat L, Syrjänen K, Zerat JC, Smith JS, Halfon P.

Gynecol Obstet Fertil. 2013 May;41(5):305-13. doi: 10.1016/j.gyobfe.2013.03.003. Epub 2013 May 3. French.

PMID:
23647817
13.

Cervical cancer prevention - current perspectives.

Monsonego J.

Endocr Dev. 2012;22:222-9. doi: 10.1159/000326691. Epub 2012 Jul 25. Review.

PMID:
22846532
14.

Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.

Monsonego J, Zerat L, Syrjänen K, Zerat JC, Smith JS, Halfon P.

Vaccine. 2012 Jul 27;30(35):5215-21. doi: 10.1016/j.vaccine.2012.06.013. Epub 2012 Jun 17.

PMID:
22713720
15.

EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease.

Arbyn M, de Sanjosé S, Saraiya M, Sideri M, Palefsky J, Lacey C, Gillison M, Bruni L, Ronco G, Wentzensen N, Brotherton J, Qiao YL, Denny L, Bornstein J, Abramowitz L, Giuliano A, Tommasino M, Monsonego J.

Int J Cancer. 2012 Nov 1;131(9):1969-82. doi: 10.1002/ijc.27650. Epub 2012 Jul 2. Review.

16.

The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy.

Arbyn M, Roelens J, Cuschieri K, Cuzick J, Szarewski A, Ratnam S, Reuschenbach M, Belinson S, Belinson JL, Monsonego J.

Int J Cancer. 2013 Jan 1;132(1):101-8. doi: 10.1002/ijc.27636. Epub 2012 Jun 13. Review.

17.

[HPV testing and cervical cancer screening. Evidences, resistances and current practices].

Monsonego J.

Gynecol Obstet Fertil. 2012 May;40(5):269-72. doi: 10.1016/j.gyobfe.2012.02.014. Epub 2012 Apr 18. French. No abstract available.

PMID:
22521159
18.

Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study).

Monsonego J, Hudgens MG, Zerat L, Zerat JC, Syrjänen K, Smith JS.

Gynecol Oncol. 2012 Apr;125(1):175-80. doi: 10.1016/j.ygyno.2012.01.002. Epub 2012 Jan 9.

PMID:
22233689
19.

[Perception and psychological impact of an abnormal Pap smear. Results of a comparative European survey].

Monsonego J, Cortés J, Pereira da Silva D, Jorge AF, Klein P.

Gynecol Obstet Fertil. 2012 Apr;40(4):213-8. doi: 10.1016/j.gyobfe.2011.10.016. Epub 2011 Dec 5. French.

PMID:
22153154
20.

Summary of the Eurogin 2011 conference: Highlighting the recent advances in HPV-related cancers.

Nicol AF, Monsonego J.

Gynecol Oncol. 2011 Nov;123(2):179-81. doi: 10.1016/j.ygyno.2011.09.009. No abstract available.

PMID:
22008409
21.

[EUROGIN 2010: roadmap on cervical cancer prevention].

Monsonego J.

Gynecol Obstet Fertil. 2011 Jul-Aug;39(7-8):462-7. doi: 10.1016/j.gyobfe.2011.05.010. Epub 2011 Jul 18. Review. French. No abstract available.

PMID:
21764621
22.

End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age.

Castellsagué X, Muñoz N, Pitisuttithum P, Ferris D, Monsonego J, Ault K, Luna J, Myers E, Mallary S, Bautista OM, Bryan J, Vuocolo S, Haupt RM, Saah A.

Br J Cancer. 2011 Jun 28;105(1):28-37. doi: 10.1038/bjc.2011.185. Epub 2011 May 31.

23.

Psychological impact, support and information needs for women with an abnormal Pap smear: comparative results of a questionnaire in three European countries.

Monsonego J, Cortes J, da Silva DP, Jorge AF, Klein P.

BMC Womens Health. 2011 May 25;11:18. doi: 10.1186/1472-6874-11-18.

24.

Genital infection with HPV in men: research into practice.

Monsonego J.

Lancet. 2011 Mar 12;377(9769):881-3. doi: 10.1016/S0140-6736(11)60277-8. Epub 2011 Feb 28. No abstract available.

PMID:
21367447
25.

Eurogin 2010 roadmap on cervical cancer prevention.

Franceschi S, Denny L, Irwin KL, Jeronimo J, Lopalco PL, Monsonego J, Peto J, Ronco G, Sasieni P, Wheeler CM.

Int J Cancer. 2011 Jun 15;128(12):2765-74. doi: 10.1002/ijc.25915. Epub 2011 Mar 25. Review.

26.

Civil society: a critical new advocate for vaccination in Europe.

Laurent-Ledru V, Thomson A, Monsonego J.

Vaccine. 2011 Jan 17;29(4):624-8. doi: 10.1016/j.vaccine.2010.11.004. Epub 2010 Nov 30. Review.

PMID:
21081178
27.

Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.

Monsonego J, Cortes J, Greppe C, Hampl M, Joura E, Singer A.

Vaccine. 2010 Nov 29;28(51):8065-72. doi: 10.1016/j.vaccine.2010.10.017. Epub 2010 Nov 16. Review.

PMID:
20971114
28.

Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study.

Monsonego J, Hudgens MG, Zerat L, Zerat JC, Syrjänen K, Halfon P, Ruiz F, Smith JS.

Int J Cancer. 2011 Aug 1;129(3):691-701. doi: 10.1002/ijc.25726. Epub 2010 Dec 8.

29.

[Anal cancer and human papillomaviruses: a perspective based on the cervical cancer model].

Monsonego J.

Gynecol Obstet Fertil. 2010 Apr;38(4):250-4. doi: 10.1016/j.gyobfe.2010.02.003. Epub 2010 Apr 1. Review. French.

PMID:
20362481
30.

Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions.

Dockter J, Schroder A, Hill C, Guzenski L, Monsonego J, Giachetti C.

J Clin Virol. 2009 Jul;45 Suppl 1:S55-61. doi: 10.1016/S1386-6532(09)70009-5.

PMID:
19651370
31.

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.

Muñoz N, Manalastas R Jr, Pitisuttithum P, Tresukosol D, Monsonego J, Ault K, Clavel C, Luna J, Myers E, Hood S, Bautista O, Bryan J, Taddeo FJ, Esser MT, Vuocolo S, Haupt RM, Barr E, Saah A.

Lancet. 2009 Jun 6;373(9679):1949-57. doi: 10.1016/S0140-6736(09)60691-7. Epub 2009 Jun 1.

PMID:
19493565
32.

EUROGIN 2007 roadmap on cervical cancer prevention.

Monsonego J.

Vaccine. 2008 Mar 14;26 Suppl 1:A1-3. No abstract available.

PMID:
18642466
33.

EUROGIN 2007 patient education conference: sharing experiences and action in cervical cancer prevention--an overview. Part 2.

Pagliusi S, Lawson H, Singer A, Monsonego J.

Vaccine. 2008 Mar 14;26 Suppl 1:A33-6. No abstract available.

PMID:
18642460
34.

The new challenges in the prevention of cervical cancer.

Monsonego J.

Vaccine. 2008 Mar 14;26 Suppl 1:A4-6. No abstract available.

PMID:
18642457
35.

Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear.

Monsonego J, Pollini G, Evrard MJ, Sednaoui P, Monfort L, Quinzat D, Dachez R, Syrjänen K.

Int J STD AIDS. 2008 Jun;19(6):385-92. doi: 10.1258/ijsa.2007.007259.

PMID:
18595876
36.

Detection of human papillomavirus genotypes among high-risk women: a comparison of hybrid capture and linear array tests.

Monsonego J, Pollini G, Evrard MJ, Sednaoui P, Monfort L, Zerat L, Syrjänen K.

Sex Transm Dis. 2008 May;35(5):521-7. doi: 10.1097/OLQ.0b013e318164e567.

PMID:
18434944
37.

Current direction in the prevention of cervical cancer.

Monsonego J.

Eur J Gynaecol Oncol. 2007;28(6):433-4.

PMID:
18179131
38.

P16(INK4a) immunocytochemistry in liquid-based cytology samples in equivocal Pap smears: added value in management of women with equivocal Pap smear.

Monsonego J, Pollini G, Evrard MJ, Sednaoui P, Monfort L, Quinzat D, Dachez R, Syrjänen K.

Acta Cytol. 2007 Sep-Oct;51(5):755-66.

PMID:
17910346
39.

[Prevention of cervical cancer (II): prophylactic HPV vaccination, current knowledge, practical procedures and new issues].

Monsonego J.

Presse Med. 2007 Apr;36(4 Pt 2):640-66. Epub 2007 Mar 12. Review. French. Erratum in: Presse Med. 2007 Jul-Aug;36(7-8):1150-1.

PMID:
17350792
40.

[Prevention of cervical cancer: screening, progress and perspectives].

Monsonego J.

Presse Med. 2007 Jan;36(1 Pt 2):92-111. Epub 2006 Dec 11. Review. French.

PMID:
17296477
41.

[Human papillomavirus prophylactic vaccines: stakes and perspectives. Gynecol Obstet Fertil 2006;34:647-55].

Monsonégo J.

Gynecol Obstet Fertil. 2007 Feb;35(2):176-7; author reply 177-8. Epub 2007 Feb 8. French. No abstract available.

PMID:
17291809
42.

[Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France].

Monsonégo J, Breugelmans JG, Bouée S, Lafuma A, Bénard S, Rémy V.

Gynecol Obstet Fertil. 2007 Feb;35(2):107-13. Epub 2007 Jan 30. French.

PMID:
17270482
43.

Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia.

Monsonego J, Pintos J, Semaille C, Beumont M, Dachez R, Zerat L, Bianchi A, Franco E.

Int J Gynecol Cancer. 2006 Mar-Apr;16(2):591-8.

PMID:
16681731
44.

Ano-rectal lymphogranuloma venereum: 22 cases reported in a sexually transmited infections center in Paris.

Halioua B, Bohbot JM, Monfort L, Nassar N, de Barbeyrac B, Monsonego J, Sednaoui P.

Eur J Dermatol. 2006 Mar-Apr;16(2):177-80.

PMID:
16581572
45.

[Cervical cancer prevention: the impact of HPV vaccination].

Monsonégo J.

Gynecol Obstet Fertil. 2006 Mar;34(3):189-201. Epub 2006 Mar 10. Review. French.

PMID:
16529969
46.

[Assessment of human papilloma virus (HPV) testing in primary screening for cervical cancer in France (May 2004). Gynecol Obstet Fertil 2005;33:357-360].

Monsonego J.

Gynecol Obstet Fertil. 2005 Nov;33(11):952-5. Epub 2005 Oct 21. French. No abstract available.

PMID:
16243571
47.

Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear.

Monsonego J, Bohbot JM, Pollini G, Krawec C, Vincent C, Merignargues I, Haroun F, Sednaoui P, Monfort L, Dachez R, Syrjänen K.

Gynecol Oncol. 2005 Oct;99(1):160-8.

PMID:
16023184
49.

[Colposcopy: the value of HPV testing in clinical practice].

Monsonego J.

Gynecol Obstet Fertil. 2004 Jan;32(1):62-74. Review. French.

PMID:
14736603
50.

Cervical cancer control, priorities and new directions.

Monsonego J, Bosch FX, Coursaget P, Cox JT, Franco E, Frazer I, Sankaranarayanan R, Schiller J, Singer A, Wright TC Jr, Kinney W, Meijer CJ, Linder J, McGoogan E, Meijer C.

Int J Cancer. 2004 Jan 20;108(3):329-33. Erratum in: Int J Cancer. 2004 Mar 1;108(6):945. Wright Tom [corrected to Wright Thomas C Jr]; Meijer Chris [corrected to Meijer Chris J L M].

Supplemental Content

Loading ...
Support Center